ATAI Life Sciences NV (ATAI)
1.875
-0.10
(-4.82%)
USD |
NASDAQ |
Apr 24, 16:00
1.87
0.00 (0.00%)
After-Hours: 20:00
ATAI Life Sciences Total Liabilities (Quarterly): 49.16M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 49.16M |
| September 30, 2023 | 39.71M |
| June 30, 2023 | 37.96M |
| March 31, 2023 | 40.08M |
| December 31, 2022 | 39.68M |
| September 30, 2022 | 46.52M |
| June 30, 2022 | 28.81M |
| Date | Value |
|---|---|
| March 31, 2022 | 29.38M |
| December 31, 2021 | 28.21M |
| September 30, 2021 | 21.35M |
| June 30, 2021 | 21.07M |
| March 31, 2021 | 25.27M |
| December 31, 2020 | 16.18M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
16.18M
Minimum
Dec 2020
49.16M
Maximum
Dec 2023
32.57M
Average
29.38M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Affimed NV | 43.50M |
| InflaRx NV | 19.48M |
| MorphoSys AG | 2.186B |
| BioNTech SE | 3.051B |
| Immatics NV | 314.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 293.48M |
| Shareholders Equity (Quarterly) | 242.96M |
| Debt to Equity Ratio | 0.0736 |
| Current Ratio | 9.224 |
| Net Debt Paydown Yield | -0.25% |